A phase II, randomized study of T-DM1 versus T-DM1 plus short induction with docetaxel in first line treatment for locally advanced or metastatic HER2+ breast cancer (SOLTI-1203) Meeting Abstract


Authors: Llombart, A.; Cortes, J.; Ciruelos, E.; Gonzalez, X.; de la Pena, L.; Villagrasa, P.; Bernedo, E.; Moreno, K.; Meya, S.; Baselga, J.
Abstract Title: A phase II, randomized study of T-DM1 versus T-DM1 plus short induction with docetaxel in first line treatment for locally advanced or metastatic HER2+ breast cancer (SOLTI-1203)
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730200124
DOI: 10.1158/1538-7445.sabcs14-ot3-1-08
PROVIDER: wos
Notes: Meeting Abstract: OT3-1-08 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga